Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "PONLIMSI"

2 News Found

Teva hits major biosimilar milestones with FDA nod and regulatory filings
Drug Approval | March 31, 2026

Teva hits major biosimilar milestones with FDA nod and regulatory filings

The US FDA has approved PONLIMSI (denosumab-adet) as a biosimilar to Prolia